InspireMD's common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the

Acasti Pharma Inc · Accelerate Diagnostics Inc · Acceleron Pharma Inc · Accell Group Active Weighting Funds ETF Trust - EventShares U.S. Policy Alpha ETF

Technical Analysis Summary for Acasti Pharma with Moving Average, Stochastics, MACD, RSI, Average Volume. Stocks: 15 20 minute delay (Cboe BZX is real-time), ET. ACST, $ACST, Acasti Pharma Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis indicators Acasti Pharma EPS beats by $0.01: Feb 9: Acasti Pharma Announces Results for Third Quarter of Fiscal 2021: Jan 27: Acasti Pharma provides update on recent financing activities: Jan 27: Acasti Pharma Provides Update on Recent Financing Activities: Jan 8: 12 Health Care Stocks Moving In Friday's Intraday Session: Jan 4: 63 Biggest Movers From Acasti Pharma Inc (ACST) stock has gained 11.08% while the S&P 500 is down -0.02% as of 1:10 PM on Thursday, Jan 21. ACST has gained $0.08 from the previous closing price of $0.76 on volume of 180,512,526 shares. MAKE SURE TO LIKE AND SUBSCRIBE FOR MORE CONTENTAsk questions in the comments i'm here to help!By Joining this Discord you acknowledge that it is not Financi 2021-04-05 · Acasti Pharma Inc. (NASDAQ:ACST)’s Biggest Investors. Upon looking at major shareholders, it appears that insiders hold 2.7% of Acasti Pharma Inc. shares, and 2.2% of them are in the hands of institutional investors.

Acasti pharma stock

But a closer examination of its Phase 3 results suggests not all is well with the company. On average, Wall Street analysts predict that . Acasti Pharma's share price could stay at $0.92 by Sep 2, 2021. The average Acasti Pharma stock price prediction forecasts a potential downside of N/A from the current ACST share price of $0.54. Acasti Pharma Inc. ("Acasti or the "Company") (NASDAQ: ACST - TSX-V: ACST) today announced its operating and financial results for the third quarter of fiscal 2021 ended December 31, 2020.

Webbplats Corealis Pharma Inc. Acasti Pharma Inc · Accelerate Diagnostics Inc · Acceleron Pharma Inc · Accell Group Active Weighting Funds ETF Trust - EventShares U.S. Policy Alpha ETF 22 okt.

Acasti Pharma Inc. is a biopharmaceutical company. The Company is focused on the research, development and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. It is developing a cardiovascular drug, CaPre (omega-3 phospholipid) for the treatment of hypertriglyceridemia.

0.60, 0.01, 2.25%, 58.10% för 6 dagar sedan — Hitta stockbilder i HD på pharma website och miljontals andra royaltyfria stockbilder, illustrationer och vektorer i Shutterstocks samling. 4 apr. 2021 — Finansiell kalender & event - Orexo; Acasti Pharma, Inc. - Class A Common Stock Aktie - Dagens Stocks and options; Best mid cap pharma 8 mars 2021 — Köp aktien Acasti Pharma, Inc. - Class A Common Stock (ACST).

Acasti Pharma, Inc. Class A Common Stock (ACST) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the… Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock Option and Equity Incentive Plans, Adoption of Amended & Restated General By-Law and Other Related Matters Approved at Its AGM View Acasti Pharma, Inc. ACST investment & stock information. Get the latest Acasti Pharma, Inc. ACST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. 2021-04-01 · Oppenheimer have made an estimate for Acasti Pharma Inc. shares, keeping their opinion on the stock as Perform, with their previous recommendation back on September 01, 2020. The new note on the price target was released on July 06, 2020, representing the official price target for Acasti Pharma Inc. stock. Acasti Pharma Inc. (ACST) Add to watchlist. NasdaqCM - NasdaqCM Real Time Price.

2021-03-15 · To see how Acasti Pharma Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: ACST stock’s performance was +4.32% in the latest trading, and +126.25% in the past year, while Bausch Health Companies Inc (BHC) has traded -3.03% on the day and positioned +105.55% higher than it was a year ago. Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the U.S. population. 2021-04-05 · To see how Acasti Pharma Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: ACST stock’s performance was -2.48% at last check in today’s session, and +83.33% in the past year, while Teva Pharmaceutical Industries Ltd (TEVA) has been trading +1.69% in recent session and positioned +35.54% 2020-01-29 · Acasti Pharma stock fell 64% on the news, and though shares rallied 24% the following day, the negative trend has persisted. Monday’s close was ACST’s lowest close since 2018. Acasti Pharma currently has 3 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ACST, but not buy more shares or sell existing shares. 2021-03-30 · Analysts gave the Acasti Pharma Inc. (ACST) stock a consensus recommendation rating of Hold, calculated at a mean rating of 2.
Bic binh an

2021-04-05 2021-04-05 Acasti Pharma stock is selling for under 0.55 as of the 9th of April 2021; that is 3.77 percent up since the beginning of the trading day. The stock's last reported lowest price was 0.52. Equity ratings for Acasti Pharma are calculated daily based on our scoring framework.The performance scores are derived for the period starting the 9th of January 2021 and ending today, the 9th of April 2021 Promoted When trading Acasti Pharma or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers.

About Acasti Pharma: Acasti Pharma is a biopharmaceutical company focused on the research, development and commercialization of prescription drugs using omega-3 (OM3) fatty acids delivered both as free fatty acids and bound-to-phospholipid esters, derived from krill oil. Co.'s primary product candidate is CaPre, an OM3 phospholipid therapeutic, which it is developing for the treatment of 2021-04-01 Today Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock Option and Equity Incentive Plans, Adoption of Amended & Restated General By-Law and Other Related Matters Approved at Its AGM 2021-03-29 Acasti Pharma Inc. ("Acasti or the "Company") (NASDAQ: ACST - TSX-V: ACST) today announced its operating and financial results for the third quarter of fiscal 2021 ended December 31, 2020. 2021-04-05 2021-04-05 Acasti Pharma stock is selling for under 0.55 as of the 9th of April 2021; that is 3.77 percent up since the beginning of the trading day. The stock's last reported lowest price was 0.52.
Plan menonita telefono

View live ACASTI PHARMA INC chart to track its stock's price action. Find market predictions, ACST financials and market news.

0.38. Acasti Pharma, Inc. - Class A Common Stock, Petroleo Brasileiro .- Petrobras American Depositary Shares, Cardiff Oncology, Inc. Social Capital AstraZeneca Horizon Pharma. 87.38, 7.20, 8.98%, 195.00%, 2021-03-30 Stock Yards Bancorp. 51.59, 0.83, 1.64%, 78.33% Acasti Pharma.

2021-03-03

Currency in USD. 0.5388 +0.0128 (+2.43%) At close: 4:00PM EDT. 2021-03-03 2020-12-02 Customizable interactive chart for Acasti Pharma with latest real-time price quote, charts, latest news, technical analysis and opinions. 2020-09-01 2020-09-01 Find the latest Acasti Pharma, Inc. (ACST) stock quote, history, news and other vital information to help you with your stock trading and investing. 2 dagar sedan · Acasti Pharma, Inc. Class A Common Stock (ACST) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 2021-04-09 · Acasti Pharma stock price target cut to $2 from $8 at B. Riley FBR. Jan. 14, 2020 at 8:56 a.m. ET by Tomi Kilgore. Acasti Pharma downgraded to neutral from buy at B. Riley FBR. 2021-03-28 · Acasti Pharma's stock was trading at $0.3849 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ACST shares have increased by 40.0% and is now trading at $0.5388.